Yukfung Lee, PA
Physician Assistant · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Yukfung Lee’s office to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$1,119
Pharmacies billed $1,119 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
76 generic and fewer than 11 brand-name prescriptions · $1,119 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Metoprolol | 17 | $48 | $3 |
Year by year
| 2024 | 79 | 17 | None | None | $1,119 |
| 2023 | 114 | 24 | 15% (17) | None | $2,750 |
| 2022 | 65 | 18 | None | None | $2,998 |
| 2021 | 83 | 28 | 17% (14) | 24% | $4,292 |
| 2020 | 86 | 26 | 14% (12) | 23% | $4,476 |
| 2019 | 68 | 15 | None | 21% | $3,417 |
| 2018 | 93 | 30 | 13% (12) | 17% | $1,498 |
| 2017 | 82 | 24 | 17% (14) | 15% | $1,977 |
| 2016 | 142 | 41 | 19% (27) | None | $2,999 |
| 2015 | 69 | 25 | None | None | $871 |
| 2014 | 78 | 28 | None | 15% | $1,061 |
| 2013 | 123 | 34 | 15% (18) | 11% | $1,783 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Metoprolol | 15 | $97 | $6 |
| Clopidogrel | 12 | $88 | $7 |
| Oxycodone | 14 | $53 | $4 |
2018: 2 drugs
| Metoprolol | 11 | $75 | $7 |
| Furosemide | 12 | $44 | $4 |
2017: 2 drugs
| Oxycodone | 11 | $134 | $12 |
| Metoprolol | 11 | $50 | $5 |
2016: 5 drugs
| Potassium Chloride | 14 | $367 | $26 |
| Oxycodone | 15 | $182 | $12 |
| Clopidogrel | 14 | $114 | $8 |
| Metoprolol | 11 | $56 | $5 |
| Furosemide | 13 | $31 | $2 |
2015: 1 drug
| Clopidogrel | 11 | $55 | $5 |
2014: 1 drug
| Furosemide | 13 | $25 | $2 |
2013: 3 drugs
| Metoprolol | 16 | $90 | $6 |
| Potassium Chloride | 12 | $53 | $4 |
| Furosemide | 14 | $32 | $2 |
Money from drug and device companies
$1,852 in 2025
| 2025 | 13 | 15 | None | $1,852 |
| 2024 | 4 | 4 | None | $511 |
| 2023 | 7 | 8 | None | $887 |
| 2022 | 4 | 5 | None | $528 |
| 2021 | 1 | 1 | None | $89 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Getinge USA Sales | Vasoview Hemopro 2 | $556 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 3 | $176 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $163 | 1 payment
|
| Gilead Sciences | None | $127 | 1 payment
|
| Madrigal Pharmaceuticals | Rezdiffra | $125 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | None | $112 | 1 payment
|
See all 15 published payments
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-10 | None | $112 |
| Edwards Lifesciences | Meals · 2025-11-13 | None | $27 |
| Maquet Cardiovascular L.L.C. | Meals · 2025-10-24 | Vasoview Hemopro 2 | $27 |
| Maquet Cardiovascular L.L.C. | Meals · 2025-10-24 | Vasoview Hemopro 2 | $17 |
| Maquet Cardiovascular L.L.C. | Meals · 2025-10-23 | Vasoview Hemopro 2 | $65 |
| Octapharma USA | Meals · 2025-10-15 | Balfaxar | $18 |
| Gilead Sciences | Meals · 2025-09-17 | None | $127 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-19 | Fasenra | $108 |
| Ipsen Biopharmaceuticals | Meals · 2025-07-24 | Bylvay | $110 |
| Abbott Laboratories | Meals · 2025-05-13 | Freestyle Libre 3 | $176 |
| Madrigal Pharmaceuticals | Meals · 2025-04-17 | Rezdiffra | $125 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-03-13 | None | $112 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-02-25 | Lifevest | $163 |
| Getinge USA Sales | Travel · 2025-02-10 | Vasoview Hemopro 2 | $556 |
| Kestra Medical Technology Services | Meals · 2025-01-31 | Assure Wcd | $109 |
See earlier years (2024, 2023, 2022, 2021)
2024: $511
| Madrigal Pharmaceuticals | Rezdiffra | $150 | 1 payment
|
| Ipsen Biopharmaceuticals | Iqirvo | $143 | 1 payment
|
| Gilead Sciences | None | $125 | 1 payment
|
| Biogen | Spinraza | $93 | 1 payment
|
2023: $887
| Intercept Pharmaceuticals | Ocaliva | $181 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $125 | 1 payment
|
| Gilead Sciences | Epclusa | $125 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | Jynarque | $125 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $116 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $110 | 1 payment
|
| Amgen | Amjevita | $105 | 1 payment
|
2022: $528
| Amgen | Avsola | $183 | 2 payments
|
| Abbvie | Vraylar | $125 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | Jynarque | $111 | 1 payment
|
| Eisai | None | $108 | 1 payment
|
2021: $89
| Baxter Healthcare | No Related Product | $89 | 1 payment
|
Professional record
- NPI
- 1013046911
- Licence
- CA PA19018
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-03-05
- NPI last updated
- 2023-03-30
- NPI record certified
- 2023-03-30
This is when the NPI record was last certified, not a medical board exam.